ICU Medical, Inc.

NASDAQ:ICUI

Medical - Instruments & Supplies

Healthcare
$178.48 +0.64%

+$0.89 today

Market cap
$4.46B
Beta
0.78
P/E (TTM)
74.2
EPS (TTM)
$1.87
52W Low $107.00High $160.29

Volume 0.21M

Average 0.29M

ICUI Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

ICU Medical, Inc.NASDAQ: ICUI

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development growth accelerates

Q2 FY2026 research & development of $22.7M rose 3.8% year over year, ahead of the -2.5% change in trailing-twelve-month research & development. Sequentially, it rose 6.7% from the prior quarter. Over 3 fiscal years it compounded at -2.0% a year.

Context

  • Research & development amounted to 3.9% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +3.8% holds above the trailing-twelve-month pace of -2.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$22.7M+6.7% QoQ
Last fiscal yearDec 2025
$87.5M-1.3% YoY
LTMJun 2026
$86.32M-2.5% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.8%——
1 year-1.3%——
3-year CAGR-2.0%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
87.5M USD
Year-over-year change
-1.3%
4-year CAGR
+16.5%

Research & Development vs competitors

How ICUI compares with its peers on the latest reported figures

  • ICUI's LTM Jun 2026 research & development of $86.32M is the 4th highest of the 5 companies compared; the peer median is $353.74M.
  • Its year-over-year change of -2.5% is the 2nd highest of 5, against a peer median of -10.8%.
  • Research & development amounts to 4.0% of revenue for ICUI, versus a peer median of 6.4%.
ICUI Competitors Peer median
Research & Development for ICUI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BDXBecton, Dickinson and CompanyLTM Sep 2026$1.07B -15.3%-7.2%5.3%
BAXBaxter International Inc.LTM Jun 2026$512M -16.6%+4.8%4.5%
TFXTeleflex IncorporatedLTM Jun 2026$195.47M +23.6%-2.0%7.5%
ICUIICU Medical, Inc.LTM Jun 2026$86.32M -2.5%-2.0%4.0%
KRMDKORU Medical Systems, Inc.LTM Mar 2026$4.59M -6.3%-4.0%10.6%
Peer median (excluding ICUI) $353.74M-10.8%-3.0%6.4%

Competitors are the stored peer set for ICUI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.32B2.28B2.26B2.38B2.23B
Cost of Revenue824.82M1.58B1.52B1.56B1.41B
Gross Profit491.49M697.76M739.87M824.78M819.66M
Gross Margin37.3%30.6%32.8%34.6%36.8%
Research & Development47.5M92.98M85.34M88.62M87.5M
Selling, General & Admin302.58M608.35M606.69M638.76M625.21M
Operating Expenses368.25M740.66M717.05M781.82M712.71M
Depreciation & Amortization89.7M235.15M228.77M219.51M200.74M
EBITDA213.86M191.55M253.2M260.04M309.29M
EBITDA Margin16.2%8.4%11.2%10.9%13.9%
Operating Income123.25M(42.9M)22.83M42.96M106.95M
Operating Margin9.4%-1.9%1.0%1.8%4.8%
Interest Income2.84M4.43M7.51M10.79M10.31M
Interest Expense858K70.81M102.73M106.54M105.38M
Other Income / Expenses(59K)(71.51M)(101.12M)(108.98M)(103.78M)
Income Before Tax123.19M(114.41M)(78.3M)(66.01M)3.17M
Pre-Tax Margin9.4%-5.0%-3.5%-2.8%0.1%
Income Tax Expense20.05M(40.12M)(48.64M)51.68M2.44M
Net Income103.14M(74.29M)(29.66M)(117.69M)732K
Net Margin7.8%-3.3%-1.3%-4.9%0.0%
EPS (Basic)4.86(3.11)(1.23)(4.83)0.03
EPS (Diluted)4.74(3.11)(1.23)(4.83)0.03
Weighted Avg Shares21.21M23.87M24.09M24.39M24.64M
Weighted Avg Shares (Diluted)21.78M23.87M24.09M24.39M24.9M

ICU Medical, Inc.

NASDAQ:ICUI

Intrinsic Alpha fair value

Locked

Current Price

$178.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.